市場調查報告書
商品編碼
1401915
2030 年病患監測設備市場預測:按產品、最終用戶和地區分類的全球分析Patient Monitoring Devices Market Forecasts to 2030 - Global Analysis By Product, By End User and By Geography |
根據 Stratistics MRC 的數據,2023 年全球病患監測設備市場規模為 469 億美元,預計在預測期內將以 11.1% 的複合年成長率成長,到 2030 年達到 981 億美元。
病患監測設備產業涉及用於監測和追蹤病患生命徵象、生理參數和整體健康狀況的設備的開發、製造和分銷。這些設備包含多種工具,從醫院床邊監視器到用於在臨床環境之外進行持續監測的攜帶式或穿戴式裝置。它經常測量心率、血壓、體溫和血氧飽和度等參數,讓醫療保健專業人員能夠即時評估患者的健康狀況,便於早期療育,並更好地進行診斷和治療。讓您可以監控狀態。
據世界衛生組織 (WHO) 稱,到 2020 年,慢性病將佔所有死亡的約 73%,佔全球疾病負擔的 60%。此外,新興經濟體佔這些疾病造成的死亡人數的 79%。
人們對穿戴式病患監測設備的興趣日益濃厚
對穿戴式病患監測設備的日益偏好是病患監測設備市場的主要促進因素。這些設備提供即時健康資料,並能夠持續遠端監測生命徵象和健康參數。其非侵入性和便利性使患者成為醫療保健的積極參與者,並促進異常和慢性疾病的早期發現。小型化和增強連接等技術進步推動了市場成長,因為穿戴式監測設備為醫療保健專業人員提供全面的見解並改善診斷和預防護理。
特定監測設備的準確性和可靠性
儘管技術進步提高了監測能力,但一些設備的準確性和可靠性仍然令人擔憂。讀數的變化、校準問題和資料解釋的不準確性可能會影響臨床決策和患者照護。此外,某些類型設備的複雜性可能會導致操作錯誤和培訓不足,從而進一步降低準確性。因此,這些設備的廣泛採用和整合到日常臨床實踐中將受到阻礙,從而阻礙市場擴張。
慢性病增加
心血管疾病、糖尿病和呼吸系統疾病等慢性疾病需要持續監測,增加了對先進病患監測設備的需求。這些設備有助於遠端健康監測、即時資料收集和及時干預,以加強患者護理和管理。隨著慢性病人口的增加,對創新和非侵入性監測解決方案的需求不斷增加,這推動了病患監測設備市場的擴張。
缺乏標準化和相容性
缺乏標準化和相容性對市場構成了重大威脅,因為它會阻礙設備和系統之間的無縫整合、資料共用和互通性。資料格式、通訊協定和設備介面的差異可能會阻礙不同監測設備和醫療IT系統之間的資訊交流。這種缺乏統一性通常會導致互通性挑戰,使醫療保健提供者難以有效地匯總、分析和利用患者資料。此外,缺乏標準化協議限制了新技術和設備與現有醫療保健生態系統的整合,這可能導致碎片化和效率低下。所有這些因素都阻礙了市場的成長。
COVID-19 的爆發加速了對遠距監護解決方案的需求,對病患監測設備市場產生了重大影響。隨著醫院變得擁擠且必須減少親自就診,遠端患者監護設備的採用量激增。此外,人們越來越關注追蹤 COVID-19 患者生命徵象和氧氣水平的先進監測系統,進一步刺激了這段時期此類設備的開發和部署。
預計在預測期內醫院部門將是最大的
在預測期內,醫院部門預計將是最大的。醫院的優勢源自於各部門監控設備的廣泛且多樣化的使用。該醫院是急診、重症患者護理、外科和專科護理的主要中心。由於許多患者需要持續監測,醫院正在大力投資先進的監測系統,以提供跨醫學專業的即時資料收集、快速干涉、準確診斷和全面的患者照護,我們正在實現這一點。
預計血糖監測系統領域在預測期內複合年成長率最高
隨著全球糖尿病盛行率的不斷上升,對高效且方便用戶使用的監測系統的需求增加,血糖監測系統領域預計將在病患監測設備市場顯著成長。此外,連續血糖監測 (CGM) 和非侵入性監測解決方案等技術進步正在提高準確性和便利性,吸引更多用戶。此外,不斷提高的醫療保健意識和政府對糖尿病管理的舉措正在推動這些監測系統的採用,從而在該細分市場中呈現出巨大的成長潛力。
有幾個因素導致北美在預測期內在病患監測設備市場佔據主導地位。該地區擁有先進的醫療基礎設施、高額醫療支出和創新醫療技術的高採用率。此外,有利的報銷政策、龐大的患者群和積極的醫療管理方法也促進了市場的成長。此外,持續的技術進步和積極的研發努力正在鞏固北美的地位。
在預測期內,由於人口快速成長、快速都市化和醫療保健支出不斷增加,亞太地區將見證病患監測設備市場的最高成長。老年人口的不斷成長以及這些慢性疾病的增加,加劇了對持續監測解決方案的需求。此外,擴大醫療基礎設施、政府促進醫療保健可近性的措施以及創新技術的採用也促進了該地區的顯著成長。
According to Stratistics MRC, the Global Patient Monitoring Devices Market is accounted for $46.9 billion in 2023 and is expected to reach $98.1 billion by 2030 growing at a CAGR of 11.1% during the forecast period. The patient monitoring devices industry is involved in the development, manufacturing, and distribution of devices used to monitor and track patients' vital signs, physiological parameters, and overall health status. These devices encompass a wide range of tools, from bedside monitors in hospitals to portable or wearable devices for continuous monitoring outside clinical settings. They often measure parameters like heart rate, blood pressure, temperature, oxygen saturation, and more, enabling healthcare professionals to assess patient health in real-time, facilitate early intervention, and monitor conditions for better diagnosis and treatment.
According to World Health Organization (WHO), chronic diseases account for around 73% of all deaths and 60% of the global burden of disease in 2020. Moreover, developing economies account for 79% of deaths attributed to these diseases.
Increasing inclination toward wearable patient monitoring devices
The growing preference for wearable patient monitoring devices serves as a key driver in the patient monitoring devices market. These devices offer real-time health data, enabling continuous and remote monitoring of vital signs and health parameters. Their non-intrusive nature and convenience empower patients to actively participate in their healthcare, promoting early detection of abnormalities and chronic conditions. With advancements in technology, including miniaturization and enhanced connectivity, wearable monitoring devices provide healthcare professionals with comprehensive insights, improving diagnosis and preventive care, thus driving market growth.
Accuracy and reliability of certain monitoring devices
While technological advancements have improved monitoring capabilities, concerns persist regarding the precision and reliability of some devices. Variations in readings, calibration issues, and inaccuracies in data interpretation can impact clinical decisions and patient care. Additionally, the complexity of certain devices may contribute to operator error or inadequate training, further compromising accuracy. Consequently, this inhibits broader adoption and integration of these devices into routine clinical practices, hindering the market expansion.
Increasing prevalence of chronic diseases
Chronic conditions like cardiovascular diseases, diabetes, and respiratory disorders demand continuous monitoring, fostering the need for advanced patient monitoring devices. These devices facilitate remote health monitoring, real-time data collection, and timely interventions, enhancing patient care and management. As the population affected by chronic illnesses rises, the demand for innovative, non-invasive monitoring solutions is growing, which is aiding in market expansion for patient monitoring devices.
Lack of standardization and compatibility
Due to its potential to hinder seamless integration, data sharing, and interoperability among devices and systems, a lack of standardization and compatibility poses a significant threat to the market. Variations in data formats, communication protocols, and device interfaces can impede the exchange of information between different monitoring devices and healthcare IT systems. This lack of uniformity often leads to interoperability challenges, making it difficult for healthcare providers to aggregate, analyze, and utilize patient data efficiently. Moreover, the absence of standardized protocols may limit the ability to incorporate new technologies and devices into existing healthcare ecosystems, leading to fragmentation and inefficiencies. All of these factors hinder market growth.
The COVID-19 pandemic significantly impacted the patient monitoring device market by accelerating the demand for remote monitoring solutions. With hospitals overwhelmed and the need to reduce in-person visits, remote patient monitoring devices experienced a surge in adoption. Additionally, there was a heightened focus on advanced monitoring systems to track vital signs and oxygen levels in COVID-19 patients, further spurring the development and deployment of such devices during this period.
The hospitals segment is expected to be the largest during the forecast period
Over the forecast period, the hospitals segment is expected to be the largest. The dominance of hospitals is attributed to their extensive and varied use of monitoring equipment across departments. Hospitals serve as primary centers for acute care, critical care, surgeries, and specialized treatments. With a high volume of patients requiring continuous monitoring, hospitals invest significantly in advanced monitoring systems to ensure real-time data collection, aiding in prompt interventions, precise diagnoses and comprehensive patient care across diverse medical specialties, which helps boost segment expansion.
The blood glucose monitoring systems segment is expected to have the highest CAGR during the forecast period
The blood glucose monitoring systems segment is poised for substantial growth in the patient monitoring device market due to the increasing prevalence of diabetes globally, which has amplified the demand for efficient and user-friendly monitoring systems. Additionally, technological advancements, such as continuous glucose monitoring (CGM) and non-invasive monitoring solutions have enhanced accuracy and convenience, attracting more users. Moreover, rising healthcare awareness, coupled with government initiatives for diabetes management, propels the adoption of these monitoring systems, indicating significant growth potential for this market segment.
During the forecast period, North America's dominance in the patient monitoring device market can be attributed to several factors. The region boasts advanced healthcare infrastructure, significant healthcare expenditure, and a high adoption rate of innovative medical technologies. Moreover, favorable reimbursement policies, a large patient pool, and a proactive approach toward healthcare management contribute to the market's growth. Additionally, continuous technological advancements and robust research & development initiatives further solidify North America's position.
During the forecast period, the Asia-Pacific region is set for the highest growth in the patient monitoring device market due to the region's burgeoning population, rapid urbanization, and increasing healthcare spending. Along with these rising chronic diseases, a growing geriatric population fuels the need for continuous monitoring solutions. Additionally, expanding healthcare infrastructure, government initiatives promoting healthcare access and the adoption of innovative technologies contribute to the region's significant growth.
Some of the key players in Patient Monitoring Devices Market include Abbott Laboratories, Boston Scientific Corporation, Draeger, Edwards Lifesciences Corporation, GE Healthcare, Infinium Medical, Masimo Corporation, Medtronic PLC, Mindray Medical International Limited, Natus Medical Incorporated, Nihon Kohden Corporation, Nonin Medical, Inc., Omron Healthcare, Philips Healthcare, Siemens Healthineers, Smiths Medical, Inc., Spacelabs Healthcare, Welch Allyn and ZOLL Medical Corporation.
In October 2023, Dozee introduces ambulatory connected patient monitoring system - 'Dozee Pro Ex' Equipped with an AI-powered early warning system that tracks the trends of vital parameters and provides timely alerts for possible clinical deterioration.
In August 2023, With FDA nod, GE HealthCare paints US launch of Portrait patient monitoring system. More than a year after unveiling its wearable, wireless patient monitoring system-with CE mark already in hand, allowing it to be used across Europe-GE HealthCare is bringing the Portrait Mobile technology across the pond. The system has secured FDA 510(k) clearance, the company announced Monday, allowing it to be used in hospitals in the U.S.
In April 2023, Honeywell has developed a real-time health monitoring system, which captures and records patients' vital signs both within the hospital setting and remotely.
Note: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa Regions are also represented in the same manner as above.